These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37579209)

  • 1. Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations.
    Feld JJ; Bruneau J; Dore GJ; Ghany MG; Hansen B; Sulkowski M; Thomas DL
    Clin Infect Dis; 2023 Aug; 77(Suppl 3):S262-S269. PubMed ID: 37579209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C Virus Vaccine Research: Time to Put Up or Shut Up.
    Hartlage AS; Kapoor A
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of a controlled human infection model for evaluation of HCV vaccine candidates.
    Barnes E; Cooke GS; Lauer GM; Chung RT
    Hepatology; 2023 May; 77(5):1757-1772. PubMed ID: 35736236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Hepatocellular Carcinoma After Spontaneous Clearance of Hepatitis C Virus and in Noncirrhosis Chronic Hepatitis C Patients With Sustained Virological Response: A Systematic Review.
    Hsu CC; Gopalakrishna H; Mironova M; Lee MH; Chen CJ; Yang HI; Wiese M; Chang KM; Wright EC; Abijo T; Feld JJ; Kaplan DE
    Clin Infect Dis; 2023 Aug; 77(Suppl 3):S245-S256. PubMed ID: 37579210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model.
    Liang TJ; Law JLM; Pietschmann T; Ray SC; Bukh J; Bull R; Chung RT; Tyrrell DL; Houghton M; Rice CM
    Clin Infect Dis; 2023 Aug; 77(Suppl 3):S257-S261. PubMed ID: 37579208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
    Jonas MC; Loftus B; Horberg MA
    Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Elimination of hepatitis C virus in Denmark].
    Døssing A; Røge BT; Madsen LG; Laursen AL; Hansen JB; Bukh J; Weis N
    Ugeskr Laeger; 2020 Feb; 182(9):. PubMed ID: 32138816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.
    Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011644. PubMed ID: 28285495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards HCV elimination among people who inject drugs in Hai Phong, Vietnam: study protocol for an effectiveness-implementation trial evaluating an integrated model of HCV care (DRIVE-C: DRug use & Infections in ViEtnam-hepatitis C).
    Rapoud D; Quillet C; Pham Minh K; Vu Hai V; Nguyen Thanh B; Nham Thi Tuyet T; Tran Thi H; Molès JP; Vallo R; Michel L; Feelemyer J; Weiss L; Lemoine M; Vickerman P; Fraser H; Duong Thi H; Khuat Thi Hai O; Des Jarlais D; Nagot N; Laureillard D;
    BMJ Open; 2020 Nov; 10(11):e039234. PubMed ID: 33208326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic strategies and promising vaccine for hepatitis C virus infection.
    Adugna A
    Immun Inflamm Dis; 2023 Aug; 11(8):e977. PubMed ID: 37647422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus: current concepts and future challenges.
    Klenerman P; Gupta PK
    QJM; 2012 Jan; 105(1):29-32. PubMed ID: 22123990
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute hepatitis C virus infection.
    Chung RT
    Clin Infect Dis; 2005 Jul; 41 Suppl 1():S14-7. PubMed ID: 16265608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development approaches for vaccines against hepatitis C virus infections].
    Bankwitz D; Krey T; Pietschmann T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Feb; 65(2):183-191. PubMed ID: 35015104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative review of HLA associations with hepatitis B and C viral infections across global populations.
    Singh R; Kaul R; Kaul A; Khan K
    World J Gastroenterol; 2007 Mar; 13(12):1770-87. PubMed ID: 17465466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of HCV in Russia: Barriers and Perspective.
    Isakov V; Nikityuk D
    Viruses; 2022 Apr; 14(4):. PubMed ID: 35458520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of primary hepatitis C virus infection among people who inject drugs in Australia pre- and post-unrestricted availability of direct acting antiviral therapies.
    Iversen J; Wand H; McManus H; Dore GJ; Maher L
    Addiction; 2023 May; 118(5):901-911. PubMed ID: 36524842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and future concepts in hepatitis C therapy.
    Pawlotsky JM
    Semin Liver Dis; 2005 Feb; 25(1):72-83. PubMed ID: 15731999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C Virus Elimination in the Human Immunodeficiency Virus-Coinfected Population: Leveraging the Existing Human Immunodeficiency Virus Infrastructure.
    Clement ME; Collins LF; Wilder JM; Mugavero M; Barker T; Naggie S
    Infect Dis Clin North Am; 2018 Jun; 32(2):407-423. PubMed ID: 29778263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Burden of pediatric hepatitis C.
    El-Shabrawi MH; Kamal NM
    World J Gastroenterol; 2013 Nov; 19(44):7880-8. PubMed ID: 24307782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and Development of Antiviral Therapies for Chronic Hepatitis C Virus Infection.
    Martinez MA; Franco S
    Adv Exp Med Biol; 2021; 1322():139-157. PubMed ID: 34258740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.